ESTA
Establishment Labs Holdings Inc. · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 45.27K | $2.90M | n/a | −1 |
| Q2 2026 | 76 | +22 | 13.17M | $1.13B | +24 | −3 |
| Q1 2026 | 58 | 0 | 10.34M | $585.94M | +5 | −5 |
| Q4 2025 | 59 | +1 | 10.18M | $741.89M | +2 | −1 |
| Q3 2025 | 14 | +1 | 2.41M | $98.60M | +2 | −1 |
| Q2 2025 | 10 | +2 | 805.95K | $34.42M | +3 | −1 |
| Q1 2025 | 5 | +1 | 867.67K | $35.40M | +3 | −2 |
| Q4 2024 | 4 | -3 | 945.57K | $43.56M | +1 | −4 |
| Q3 2024 | 6 | 0 | 564.99K | $24.45M | +1 | −1 |
| Q2 2024 | 6 | n/a | 599.33K | $27.23M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 45.27K | -83.3% | $2.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Wealth Enhancement Advisory… | $211,272 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 174 holders, 26.39M shares, $1.49B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.